Literature DB >> 12538545

Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Demet Karnak1, Oya Kayacan, Sumru Beder, Mustafa Delibalta.   

Abstract

Idiopathic hypereosinophilic syndrome is characterized by prolonged eosinophilia without an identifiable underlying cause and multiple-organ dysfunction, most frequently involving the heart, the central or peripheral nervous system and the lungs. We describe a case in which a patient with asthma who had idiopathic hypereosinophilic syndrome with pulmonary involvement presented with symptoms of pulmonary embolism and left ventricular thrombus.

Entities:  

Mesh:

Year:  2003        PMID: 12538545      PMCID: PMC140426     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  24 in total

Review 1.  The diagnosis and treatment of cough.

Authors:  R S Irwin; J M Madison
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  Hypereosinophilic syndrome presenting as acute myocardial infarction.

Authors:  A Mor; A Segev; R Hershkovits; S Lew; Y A Mekori
Journal:  Allergy       Date:  2000-09       Impact factor: 13.146

3.  Parietal fibroplastic endocarditis with blood eosinophilia.

Authors:  A ZOLI
Journal:  Cardiologia       Date:  1951

4.  Chronic eosinophilic pneumonia: a case report.

Authors:  A Phunmanee; W Boonsawat; D J Charoensiri; C Limkunacul
Journal:  J Med Assoc Thai       Date:  2000-08

5.  Idiopathic hypereosinophilic syndrome in 3 Rottweilers.

Authors:  J E Sykes; D J Weiss; L C Buoen; M M Blauvelt; D W Hayden
Journal:  J Vet Intern Med       Date:  2001 Mar-Apr       Impact factor: 3.333

Review 6.  Pulmonary disease of vascular origin.

Authors:  D E Dines
Journal:  Dis Chest       Date:  1968-07

7.  The hypereosinophilic syndromes.

Authors:  W R Hardy; R E Anderson
Journal:  Ann Intern Med       Date:  1968-06       Impact factor: 25.391

Review 8.  The hypereosinophilic syndrome: clinical features, laboratory findings and treatment.

Authors:  C J Spry
Journal:  Allergy       Date:  1982-11       Impact factor: 13.146

Review 9.  Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

Review 10.  Hypereosinophilia.

Authors:  B J Bain
Journal:  Curr Opin Hematol       Date:  2000-01       Impact factor: 3.284

View more
  6 in total

1.  From an isolated right ventricular thrombus to the diagnosis of the hypereosinophilic syndrome.

Authors:  Shokoufeh Hajsadeghi; Mitra Chitsazan; Hamid Reza Pouraliakbar; Alireza Sadeghipour
Journal:  J Cardiol Cases       Date:  2011-03-27

2.  Response to corticosteroids and cytotoxic drugs in a case of idiopathic hypereosinophilic syndrome with predominantly elevated eosinophils and multiple clinical manifestations.

Authors:  Zhi-Ping Guo; Lin-Hua Yang; Jian-Fang Chen; Xiu-Hua Chen; Yao-Fang Zhang
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-08       Impact factor: 0.900

3.  [Hypereosinophilic dermatitis. An overlooked diagnosis?].

Authors:  N Kemmler; W K Peitsch; E Glorer; S Goerdt
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

4.  Large apical thrombus in a patient with persistent heart failure and hypereosinophilia: Löffler endocarditis.

Authors:  A Altug Cincin; Beste Ozben; M Azra Tanrikulu; Ozdil Baskan; Mehmet Agirbasli
Journal:  J Gen Intern Med       Date:  2008-07-10       Impact factor: 5.128

5.  Clinical analysis of hypereosinophilic syndrome first presenting with asthma-like symptoms.

Authors:  Xuan Wei; Xiaofeng Li; Zuyou Wei; Hui Zhang; Jiehua Deng; Suke Xing; Jianquan Zhang
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

Review 6.  Cough in hypereosinophilic syndrome: case report and literature review.

Authors:  Jiaxing Xie; Jianheng Zhang; Xiaoxian Zhang; Qingling Zhang; Kian Fan Chung; Chunyan Wang; Kefang Lai
Journal:  BMC Pulm Med       Date:  2020-04-15       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.